Trump asks drugmakers to cut U.S. prices within 60 days

President Donald Trump said he wanted to take steps from major pharmaceutical companies to reduce the prices of US drugs within the next 60 days.

In fact, Trump released individual letters to 17 drug producers on Thursday, on Thursday, Eli Lilly, GSK– Pfizer– Regenonon– LensAnd Novo Nordisk.

Trump threatened to “distribute the vehicle to our Arsenal to protect American families from constantly abusive drug pricing practices” if companies refuse to comply.

Letters come in May after Trump signed a controversial executive order that portrays a controversial plan aimed at reducing drug costs by connecting the prices of some drugs in the United States to those who significantly lower abroad. Trump’s last effort to try to restrain US prescription drug prices. Average two to three times higher According to Rand Corp, a public policy think tank, in other developed countries – and 10 times more than certain countries.

In his letters on Thursday, Trump said that drug producers offer potential solutions for high US drug prices. However, these proposals “in the same way: change the crime and policy changes that will result in the sector with billions of dollars of working paper,” he said.

He said in the future, “American families will accept their commitments to ensure that they are immediately relieved of inflated drug prices and an end to the free journey of American innovation by Europe and other developed countries”. Trump said that a collaborative effort to reduce US drug prices would be the “most effective way” for companies, government and patients.

The phrma spokesman, the largest lobby group of the industry, did not respond immediately to the request for comments.

Drug producers are also preparing for the president’s planned tariffs on drugs imported to the United States.

This is the last minute news. Please refresh for updates.